Cholesterol Screening/ Cholesterol Lab Testing Services Market Size, Share, Analysis Report

Cholesterol Screening/ Cholesterol Lab Testing Services Market By Type of Customer Analysis (Physicians/Providers and Hospitals, Employers, Health Plans, and Managed Care Organizations (MCOs), Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs), Patients) and By Regional Analysis – Global Forecast by

The Cholesterol Screening/ Cholesterol Lab Testing Services Market is expected to be around US$ 28.40 Billion by 2028 at a CAGR of 8% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Novartis International
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Spectra Laboratories Inc
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    8

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Cholesterol is also one of the part of the substance system that is created by our body to keep our body healthy and well-functioning. Cholesterol plays a very important role in the individuals healthy heart. Cholesterol screening is a test that is done at a lab by a doctor or a certified person by taking sample of blood from your body.Then the sample blood analyses are done at a laboratory and results will be provided at proper time interval. There are different types of screening relating to cholesterol testing like full lipid test. High level of cholesterol leads to risks of heart disease, stroke, atherosclerosis, a clogging or hardening of your arteries. A blood test is a outpatient procedure and is relatively painless and it requires only a couple of minute. Due to growing risks of heart failure and obesity cholesterol testing is gaining scope globally. It is better to check your cholesterol level at a regular time to avoid risks.

    How Big is the Global Cholesterol Screening/ Cholesterol Lab Testing Services Market?

    The Cholesterol Screening/ Cholesterol Lab Testing Services Market is expected to be around US$ 28.40 Billion by 2028 at a CAGR of 8% in the given forecast period.

    The major driving factors of Cholesterol Screening/ Cholesterol Lab Testing Services Market are as follows:

    • High frequency of perpetual infections
    • Obesity and cardiovascular diseases are growing
    • Growth in the Geriatric Population
    • Growing knowledge about healthcare and taking preventive measures against it
    • Government involvement to make better testing facility

    The restraining factors of Cholesterol Screening/ Cholesterol Lab Testing Services Market are as follows:

    • Developing home/self-testing market
    • Emergence of noninvasive cholesterol testing techniques

    The Cholesterol Screening/ Cholesterol Lab Testing Services Marketis segmented on the lines of its type of customer and regional. Based on type of customer segmentation it covers physicians/providers and hospitals, government agencies, accountable care organizations (ACOs), and integrated delivery networks (IDNs), patients.The Cholesterol Screening/ Cholesterol Lab Testing Services Marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:
    1) An overview of the global market for Cholesterol Screening/ Cholesterol Lab Testing Services Marketand related technologies.
    2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
    3) Identifications of new market opportunities and targeted promotional plans for Cholesterol Screening/ Cholesterol Lab Testing Services Market.

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    REPORT SCOPE:
    The scope of the report includes a detailed study of global and regional markets on Cholesterol Screening/ Cholesterol Lab Testing Services Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (U.S.), Clinical Reference Laboratory, Inc. (CRL) (U.S.), ACM Medical Laboratory (U.S.), and Adicon Clinical Laboratory (China).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    The Cholesterol Screening/ Cholesterol Lab Testing Services Market has been segmented as below:

    By Type of Customer Analysis:

    • Physicians/Providers and Hospitals
    • Employers, Health Plans, and Managed Care Organizations (MCOs)
    • Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs)
    • Patients

    By Regional Analysis

    North America
    Europe
    Asia-Pacific
    Rest of the World

    Reasons to Buy this Report:
    1) Obtain the most up to date information available on all Cholesterol Screening/ Cholesterol Lab Testing Services Market .

    2) Identify growth segments and opportunities in the industry.
    3) Facilitate decision making on the basis of strong historic and forecast of Cholesterol Screening/ Cholesterol Lab Testing Services Market data.
    4) Assess your competitor’s refining portfolio and its evolution.

    Customization:
    We can offer you custom research reports as per client’s special requirements.

    Gas Chromatography Market

    Gemfibrozil Sales Market

    Generic Drugs Market

    Genome Editing Market

    Geriatric Medicine Market

    1    INTRODUCTION     

        1.1    Key Take Aways    
        1.2    Report Description    
        1.3    Markets Covered    
        1.4    Stakeholders    
        1.5    Research Methodology    
            1.5.1    Market Size    
            1.5.2    Market Share    
            1.5.3    Key Data Points From Secondary Sources    
            1.5.4    Key Data Points From Primary Sources

    2 Research Methodology
        2.1 Cholesterol Testing Market Size Estimation 
        2.2 Cholesterol Testing  Market Breakdown and Data Triangulation 
        2.3 Key Data From Secondary Sources 
        2.4 Key Data From Primary Sources
        2.5 Assumptions

    3 Executive Summary

    4 Premium Insights
        4.1 Cholesterol Testing Market Overview 
        4.2 Cholesterol Testing Services Market, By Type of Customer  
        4.3 Geographic Snapshot: Cholesterol Testing Services Market

    5 Industry Insights
        5.1 Cost Structure & Pricing Analysis 
        5.2 Reimbursement Scenario

    6 Market Dynamics
        6.1 Introduction 
        6.2 Market Drivers 
               6.2.1 Increasing Incidence of Cardiovascular Diseases (CVDs) and Obesity
               6.2.2 Physician’s Preference for Lab Testing Over Self-Testing
               6.2.3 Growing Awareness and Adoption of Preventive Healthcare
               6.2.4 Government Initiatives to Improve Quality of Testing
               6.2.5 Rapid Growth in the Geriatric Population
        6.2 Market Restraints 
               6.3.1 Rapidly Growing Cholesterol Home/Self-Testing Market
               6.3.2 Emergence of Noninvasive Cholesterol Testing Methods
        6.3 Market Opportunities  
               6.4.1 High Growth Potential in Emerging Economies 
               6.4.2 Patient-Initiated Testing to Foster Market Growth in Developed Countries
        6.4 Market Challenges 
               6.5.1 Patient Data Security
               6.5.2 Evolving Regulatory Policies

    7 Non-Pharmacological Treatment Market
        6.1 Introduction  
               6.1.1 Cognitive Behavioral Therapy for Insomnia (CBTI) 
               6.1.2    Hypnotherapy
               6.1.3 Other Alternative Therapies
        6.2 Therapy Recommendation, 2015 (%)  
        6.3 Qualitative Assessment

    8 Cholesterol Testing/Cholesterol Screening Services Market, By Type of Customer
        8.1 Physicians/Providers and Hospitals 
        8.2 Employers, Health Plans, and Managed Care Organizations (MCOs) 
        8.3 Government Agencies, Accountable Care Organizations, and Integrated Delivery Networks (IDNs) 
        8.4 Patients

    9 Regional Analysis
        9.1 Introduction 
        9.2 North America 
               9.2.1 U.S.
               9.2.2 Canada
        9.3 Europe 
               9.3.1 U.K.
               9.3.2 Germany
               9.3.3 France
               9.3.4 Italy
               9.3.5 Spain
               9.3.6 Rest of Europe
        9.4 Asia 
        9.5 Rest of the World

    10 Competitive Landscape
        10.1 Overview  
        10.2 Market Share Analysis 
        10.3 Competitive Situation and Trends  
               10.3.1 Acquisitions
               10.3.2 Expansions and Investments
               10.3.3 Agreements
               10.3.4 Service Launches

    11 Company Profiles
         11.1 Laboratory Corporation of America Holdings (Labcorp)  
         11.2 Quest Diagnostics Incorporated 
         11.3 Eurofins Scientific 
         11.4 Spectra Laboratories, Inc. 
         11.5 Unilabs  
         11.6 Synlab International GmbH 
         11.7 Bio-Reference Laboratories, Inc. 
         11.8 Clinical Reference Laboratory, Inc. 
         11.9 ACM Medical Laboratory)  
         11.10 Adicon Clinical Laboratory

    The Cholesterol Screening/ Cholesterol Lab Testing Services Market has been segmented as below:

    By Type of Customer Analysis:

    • Physicians/Providers and Hospitals
    • Employers, Health Plans, and Managed Care Organizations (MCOs)
    • Government Agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs)
    • Patients

    By Regional Analysis

         North America
         Europe
         Asia-Pacific
         Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 8% during the study period (2023-2028)
    The Cholesterol Screening/ Cholesterol Lab Testing Services Market is expected to be around US$ 28.40 Billion by 2028
    The segment included in the Cholesterol Screening/ Cholesterol Lab Testing Services Market is Type of Customer and region.
    Some key players operating in the Cholesterol Screening/ Cholesterol Lab Testing Services Market include Novartis International Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs (Switzerland), SYNLAB International GmbH
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports